REGENERON PHARMACEUTICALS, INC. - COM (REGN)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / COM
Number of holders
438
Total Shares
3.78M
Shares change
+103K
Total reported value, excl. options
$2.68B
Value change
+$40.4M
Put/Call ratio
161.89
Number of buys
179
Number of sells
-241
Price
$712.33
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.